CorMedix Inc.·4

Sep 9, 8:47 AM ET

Lefkowitz Steven W 4

4 · CorMedix Inc. · Filed Sep 9, 2020

Insider Transaction Report

Form 4
Period: 2020-09-04
Transactions
  • Purchase

    Common Stock

    2020-09-04$3.98/sh+2,215$8,81660,498 total
  • Purchase

    Common Stock

    2020-09-04$4.00/sh+3,500$14,00058,283 total
Holdings
  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.85Exp: 2028-02-16Common Stock (8,000 underlying)
    8,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $5.63Exp: 2030-02-25Common Stock (15,000 underlying)
    15,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $2.25Exp: 2027-06-25Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: By Spouse)
    2,000
  • Stock Option (Right to Buy Common Stock)

    Exercise: $8.30Exp: 2029-01-10Common Stock (15,000 underlying)
    15,000
  • Common Stock

    (indirect: Wade Capital Corp Money Purchase Plan)
    30,152
Footnotes (5)
  • [F1]The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
  • [F2]These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
  • [F3]These options were granted on 01/10/2019. The options are fully vested.
  • [F4]These options were granted on 2/16/2018. These options are fully vested.
  • [F5]These options were granted on 6/25/2017. These options are fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    PRIMARY DOCUMENT